Microport Cardioflow Medtech Corp
HKEX:2160
Intrinsic Value
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. [ Read More ]
The intrinsic value of one
Microport Cardioflow Medtech Corp
stock under the Base Case scenario is
1.19
HKD.
Compared to the current market price of 0.95 HKD,
Microport Cardioflow Medtech Corp
is
Undervalued by 20%.
Microport Cardioflow Medtech Corp's market capitalization is 2.3B HKD.
Microport Cardioflow Medtech Corp stock price is 0.95 HKD.
Microport Cardioflow Medtech Corp stock price (0.95 HKD) is 20% less than its Intrinsic Value (1.19 HKD).
Microport Cardioflow Medtech Corp stock price (0.95 HKD) is 26% less than its DCF Value (1.28 HKD). Open DCF Valuation
Microport Cardioflow Medtech Corp stock price (0.95 HKD) is 13% less than its Relative Value (1.09 HKD). Open Relative Valuation
Microport Cardioflow Medtech Corp has upside potential of 292% compared to the average analyst price target.
Open Wall St Estimates
Microport Cardioflow Medtech Corp's Revenue has grown by an exceptional 34% over the past 12 months.
Microport Cardioflow Medtech Corp has positive Gross Profit for the last twelve months.
Microport Cardioflow Medtech Corp's Revenue is forecast to grow at a rate of 29% per year over the next 3 years.
Microport Cardioflow Medtech Corp's ROE (Return on Equity) for the past 12 months is negative and is equal to -19%.
Microport Cardioflow Medtech Corp has negative Operating Income for the last twelve months.
Microport Cardioflow Medtech Corp has negative Net Income for the last twelve months.
Microport Cardioflow Medtech Corp's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -32%.
Microport Cardioflow Medtech Corp has negative Free Cash Flow for the last twelve months.
Microport Cardioflow Medtech Corp has negative three-year average ROE (Return on Equity): -13%. The company is not efficient at transforming stockholders' equity into net income.
Microport Cardioflow Medtech Corp's D/E (Debt to Equity) is very low and is equal to 0.02.
Microport Cardioflow Medtech Corp has negative three-year average ROIC (Return on Invested Capital): -35%. The company is not efficient at using invested capital to generate operating income.
Microport Cardioflow Medtech Corp's short-term assets (2B CNY) exceed its short-term liabilties (194m CNY).
Microport Cardioflow Medtech Corp's long-term assets (3B CNY) exceed its long-term liabilties (242m CNY).
Microport Cardioflow Medtech Corp has negative Net Debt. This means that the company has more cash and short-term investments (2B CNY) than debt (42m CNY).
Microport Cardioflow Medtech Corp's Altman Z-Score is very high and is equal to 10.78.
Microport Cardioflow Medtech Corp doesn't generate enough operating income (-264m CNY) to safely cover interest payments on its debt (7m CNY).
Valuation Backtest
Microport Cardioflow Medtech Corp
Run backtest to discover the historical profit from buying and selling
Microport Cardioflow Medtech Corp
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Microport Cardioflow Medtech Corp
Balance Sheet Decomposition
Microport Cardioflow Medtech Corp
| Current Assets | 2B |
| Cash & Short-Term Investments | 1.8B |
| Receivables | 144.8m |
| Other Current Assets | 122.9m |
| Non-Current Assets | 535.8m |
| Long-Term Investments | 167.4m |
| PP&E | 197m |
| Intangibles | 143.9m |
| Other Non-Current Assets | 27.5m |
| Current Liabilities | 193.6m |
| Accounts Payable | 152.9m |
| Other Current Liabilities | 40.7m |
| Non-Current Liabilities | 48.7m |
| Long-Term Debt | 41.9m |
| Other Non-Current Liabilities | 6.8m |
Earnings Waterfall
Microport Cardioflow Medtech Corp
|
Revenue
|
336.2m
CNY
|
|
Cost of Revenue
|
-329.3m
CNY
|
|
Gross Profit
|
6.9m
CNY
|
|
Operating Expenses
|
-270.5m
CNY
|
|
Operating Income
|
-263.5m
CNY
|
|
Other Expenses
|
-208m
CNY
|
|
Net Income
|
-471.5m
CNY
|
Free Cash Flow Analysis
Microport Cardioflow Medtech Corp
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Microport Cardioflow Medtech Corp's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Microport Cardioflow Medtech Corp's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Microport Cardioflow Medtech Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Microport Cardioflow Medtech Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Microport Cardioflow Medtech Corp
According to Wall Street analysts, the average 1-year price target for
Microport Cardioflow Medtech Corp
is 3.72 HKD
with a low forecast of 2.22 HKD and a high forecast of 6.3 HKD.
Shareholder Return
Price
Microport Cardioflow Medtech Corp
| Average Annual Return | -53.29% |
| Standard Deviation of Annual Returns | 38.11% |
| Max Drawdown | -96% |
| Market Capitalization | 2.3B HKD |
| Shares Outstanding | 2 412 379 904 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Microport Cardioflow Medtech Corp
Country
Industry
Market Cap
Dividend Yield
Description
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one
Microport Cardioflow Medtech Corp
stock under the Base Case scenario is
1.19
HKD.
Compared to the current market price of 0.95 HKD,
Microport Cardioflow Medtech Corp
is
Undervalued by 20%.
You don't have any saved screeners yet
